HealthDay News — Isradipine does not appear to slow progression of disability in patients with de novo Parkinson disease (PD), according to a study presented at the annual meeting of the American Academy of Neurology, held from May 4 to 10 in Philadelphia. Tanya Simuni, MD, from the Northwestern University Feinberg School of Medicine in…
A group of investigators discussed clinical trials from multiple neurology society meetings that impact patient care during an AAN 2019 clinical trial plenary session.
Investigators assessed a large population of Italian patients with resistant multiple sclerosis spasticity treated with THC:CBD to determine real-life, long-term efficacy outcomes.
Investigators analyzed adherence to monotherapy antiepileptic drug therapy for patients with focal seizures receiving eslicarbazepine acetate vs generic carbamazepine and oxcarbazepine.
Researchers analyzed dietary treatment in childhood drug-resistant epilepsy at a tertiary care in India over the past 12 years.
Researchers investigated the long-term risk for stroke in women with prior history of hypertensive disorders during pregnancy.
Investigators sought to determine the risk for intracerebral hemorrhage in pregnancy and during the postpartum period.
Increased waist-to-hip ratio is associated with a higher risk for ischemic stroke and may predict stroke risk more accurately than measures of body mass index.
During a migraine attack, experiencing nausea with and without vomiting is associated with nonadherence to acute migraine medication guidelines.
Researchers sought to determine whether combining memantine with a cholinesterase inhibitor produced early and consistent improvements in cognition for patients with moderate to severe Alzheimer disease.
An association between migraine and metabolic syndrome was observed only in women with a past history of migraine.
Older men with type 2 diabetes who received metformin or newer hypoglycemic medication had less cognitive decline compared with those who received sulfonylureas.
Use of zonisamide showed long-term efficacy for Parkinsonism and dementia with Lewy bodies without deterioration of cognitive function.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may represent effective migraine prophylactic treatments.
Long-term adjunctive treatment with amantadine may enable the levodopa regimen to be optimized in patients with Parkinson experiencing motor complications.